Abstract
Despite interest in phosphoinositide (PtdIns) kinases, such as PtdIns 3 kinases (PI3K), as targets for controlling plasma membrane PtdIns levels in disease, the PtdIns have another less well-known site of action in the cell nucleus.
Recent studies show that PtdIns use a variety of strategies to alter DNA responses. Here, we provide an overview of these newly identified forms of gene expression control, which should be considered when studying the therapeutic use of PtdIns-directed compounds. As PI3K is one of the most important clinical targets in recent years, we will focus on two polyphosphoinositides, the PI3K substrate PtdIns(4,5)di-phosphate (PI4,5P2) and its product PtdIns(3,4,5)tri-phosphate (PI3,4,5P3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn JY, Liu X, Cheng D et al (2005) Nucleophosmin/B23, a nuclear PI (3,4,5)P3 receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol Cell 18:435–445
Alva V, Lupas AN (2016) The TULIP superfamily of eukaryotic lipid-binding proteins as a mediator of lipid sensing and transport. Biochem Biophys Acta 1861:913–923
Alvarez B, Martínez-A C, Burgering B et al (2001) Forkhead transcription factors contribute to the execution of the mitotic program in mammals. Nature 413:744–747
Angulo I, Vadas O, Garçon F et al (2013) Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 342:866–871
Attree O, Olivos IM, Okabe I et al (1992) The Lowe’s oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358:239–242
Balla T (2005) Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J Cell Sci 118:2093–2104
Bidlingmaier S, Liu B (2007) Interrogating yeast surface-displayed human proteome to identify small molecule-binding proteins. Mol Cell Proteomics 11:2012–2020
Blind RD, Suzawa M, Ingraham HA (2012) Direct modification and activation of a nuclear receptor-PIP2 complex by the inositol lipid kinase IPMK. Sci Signal 5:ra44
Blind RD, Sablin EP, Kuchenbecker KM et al (2014) The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1. Proc Natl Acad Sci U S A 111:15054–15059
Bolino A, Muglia M, Conforti FL et al (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25:17–19
Boronenkov IV, Loijens JC, Umeda M et al (1998) Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 9:3547–3560
Carpentier S, N’Kuli F, Grieco G et al (2013) Class III phosphoinositide 3-kinase/VPS34 and dynamin are critical for apical endocytic recycling. Traffic 14:933–948
Catimel B, Yin MX, Schieber C et al (2009) PI(3,4,5)P3 interactome. J Proteome Res 8:3712–3726
Chen ZH, Zhu M, Yang J et al (2014) PTEN interacts with histone H1 and controls chromatin condensation. Cell Rep 8:2003–2014
Chiu YH, Lee JY, Cantley LC (2014) BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity. Mol Cell 54:193–202
Cocco L, Martelli AM, Gilmour RS et al (1988) Rapid changes in phospholipid metabolism in the nuclei of Swiss 3T3 cells induced by treatment of the cells with insulin-like growth factor I. Biochem Biophys Res Commun 154:1266–1272
D’Angelo G, Vicinanza M, De Matteis MA (2008) Lipid-transfer proteins in biosynthetic pathways. Curr Opin Cell Biol 20:360–370
Devereaux K, Dall’Armi C, Alcazar-Roman A et al (2013) Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis. PLoS One 8:e76405
Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651–657
Dornan GL, Siempelkamp BD, Jenkins ML et al (2017) Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A 118:1982–1987
Endo A, Kitamura N, Komada M (2009) Nucleophosmin/B23 regulates ubiquitin dynamics in nucleoli by recruiting deubiquitylating enzyme USP36. J Biol Chem 284:27918–27923
Falasca M, Maffucci T (2012) Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 443:587–601
Fayngerts SA, Wu J, Oxley CL et al (2014) TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell 26:465–478
Fruman DA, Chiu H, Hopkins BD et al (2017) The PI3K pathway in human disease. Cell 170:605–635
Funderburk SF, Wang QJ, Yue Z (2010) The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol 20:355–362
Gallego O, Betts MJ, Gvozdenovic-Jeremic J et al (2010) A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae. Mol Syst Biol 6:430
García Z, Kumar A, Marqués M et al (2006) PI3K controls early and late events in mammalian cell division. EMBO J 25:655–661
Gelato KA, Tauber M, Ong MS et al (2014) Accessibility of different histone H3-binding domains of UHRF1 is allosterically regulated by phosphatidylinositol 5-phosphate. Mol Cell 54:905–919
Goldsmith JR, Chen YH (2017) Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins. Cell Mol Immunol 14:482–487
Grisendi S, Mecucci C, Falini B et al (2006) Nucleophosmin and cancer. Nat Rev Cancer 6:493–505
Hamann BL, Blind RD (2018) Nuclear phosphoinositide regulation of chromatin. J Cell Physiol 233:107–123
Hempel WM, Cavanaugh AH, Hannan RD et al (1996) The species-specific RNA polymerase I transcription factor SL-1 binds to upstream binding factor. Mol Cell Biol 16:557–563
Jones DR, Bultsma Y, Keune WJ et al (2006) Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta. Mol Cell 23:685–695
Jungmichel S, Sylvestersen KB, Choudhary C et al (2014) Specificity and commonality of the phosphoinositide-binding proteome analyzed by quantitative mass spectrometry. Cell Rep 6:578–591
Kandoth C, McLellan MD, Vandin F et al (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:333–339
Kim SJ (1998) Insulin rapidly induces nuclear translocation of PI3-kinase in HepG2 cells. Biochem Mol Biol Int 46:187–196
Krylova IN, Sablin EP, Moore J et al (2005) Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343–355
Kumar A, Fernadez-Capetillo O, Carrera AC (2010) Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair. Proc Natl Acad Sci U S A 107:7491–7496
Kumar A, Redondo-Muñoz J, Perez-García V et al (2011) Nuclear but not cytosolic phosphoinositide 3-kinase beta plays an essential function in cell survival. Mol Cell Biol 31:2122–2133
Kurek KC, Luks VL, Ayturk UM et al (2012) Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 90:1108–1115
Laporte J, Hu LJ, Kretz C et al (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13:175–182
Lees JA, Messa M, Sun EW et al (2017) Lipid transport by TMEM24 at ER-plasma membrane contacts regulates pulsatile insulin secretion. Science 355(6326):eaah6171
Lete MG, Sot J, Ahyayauch H et al (2014) Histones and DNA compete for binding polyphosphoinositides in bilayers. Biophys J 106:1092–1100
Lindmo K, Stenmark H (2006) Regulation of membrane traffic by phosphoinositide 3-kinases. J Cell Sci 119:605–614
Lindsay Y, McCoull D, Davidson L et al (2006) Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J Cell Sci 119:5160–5168
Liu P, Cheng H, Roberts TM et al (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8:627–644
Lu PJ, Hsu AL, Wang DS et al (1998) Phosphoinositide 3-kinase in rat liver nuclei. Biochemistry 37:5738–5745
Maraldi NM, Capitani S, Caramelli E et al (1984) Conformational changes of nuclear chromatin related to phospholipid induced modifications of the template availability. Adv Enzym Regul 22:447–464
Marqués M, Kumar A, Poveda AM et al (2009) Specific function of phosphoinositide 3-kinase beta in the control of DNA replication. Proc Natl Acad Sci U S A 106:7525–7530
Martelli AM, Manzoli L, Cocco L (2004) Nuclear inositides: facts and perspectives. Pharmacol Ther 101:47–64
Martincorena I, Campbell PJ (2015) Somatic mutation in cancer and normal cells. Science 349:1483–1489
Mellman DL, Gonzales ML, Song C et al (2008) A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs. Nature 451:1013–1017
Monserrate JP, York JD (2010) Inositol phosphate synthesis and the nuclear processes they affect. Curr Opin Cell Biol 22:365–373
Neri LM, Martelli AM, Borgatti P et al (1999) Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-f translocation to the nucleus of NGF-treated PC12 cells. FASEB J 13:2299–2310
Nicot AS, Laporte J (2008) Endosomal phosphoinositides and human diseases. Traffic 9:1240–1249
Nile AH, Bankaitis VA, Grabon A (2010) Mammalian diseases of phosphatidylinositol transfer proteins and their homologs. Clin Lipidol 5:867–897
Okada M, Jang SW, Ye K (2008) Akt phosphorylation and nuclear phosphoinositide association mediate mRNA export and cell proliferation activities by ALY. Proc Natl Acad Sci U S A 105:8649–8654
Pang J, Yang YW, Huang Y et al (2017) p110β inhibition reduces histone H3K4 Di-methylation in prostate cancer. Prostate 77:299–308
Poli A, Billi AM, Mongiorgi S et al (2016) Nuclear phosphatidylinositol signaling: focus on phosphatidylinositol phosphate kinases and phospholipases C. J Cell Physiol 231:1645–1655
Quaresma AJ, Sievert R, Nickerson JA (2013) Regulation of mRNA export by the PI3 kinase/AKT signal transduction pathway. Mol Biol Cell 24:1208–1221
Rando OJ, Zhao K, Janmey P et al (2002) Phosphatidylinositol-dependent actin filament binding by the SWI/SNF-like BAF chromatin remodeling complex. Proc Natl Acad Sci U S A 99:2824–2829
Redondo-Muñoz J, Pérez-García V, Carrera AC (2014) Phosphoinositide 3-kinase beta: when a kinase is more than a kinase. Trends Cell Mol Biol 8:83–92
Redondo-Muñoz J, Pérez-García V, Rodríguez MJ et al (2015) Phosphoinositide 3-kinase beta protects nuclear envelope integrity by controlling RCC1 localization and ran activity. Mol Cell Biol 35:249–263
Resnick AC, Snowman AM, Kang B et al (2005) Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. Proc Natl Acad Sci U S A 102:12783–12788
Rowland MM, Bostic HE, Gong D et al (2011) Phosphatidylinositol 3,4,5-trisphosphate activity probes for the labeling and proteomic characterization of protein binding partners. Biochemistry 50:11143–11161
Sablin EP, Blind RD, Krylova IN et al (2009) Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. Mol Endocrinol 23:25–34
Shah ZH, Jones DR, Sommer L et al (2013) Nuclear phosphoinositides and their impact on nuclear functions. FEBS J 280:6295–6310
Silió V, Redondo-Muñoz J, Carrera AC (2012) Phosphoinositide 3-kinase beta regulates chromosome segregation in mitosis. Mol Biol Cell 23:4526–4542
Smith KP, Moen PT, Wydner KL et al (1999) Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific. J Cell Biol 144:617–629
Spangle JM, Dreijerink KM, Groner AC et al (2016) PI3K/AKT signaling regulates H3K4 methylation in breast cancer. Cell Rep 15:2692–2704
Stijf-Bultsma Y, Sommer L, Tauber M et al (2015) The basal transcription complex component TAF3 transduces changes in nuclear phosphoinositides into transcriptional output. Mol Cell 58:453–467
Stopkova P, Saito T, Papolos DF et al (2004) Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol Psychiatry 55:981–988
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M et al (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11:329–341
Ye K, Hurt KJ, Wu FY et al (2000) Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell 103:919–930
Yildirim S, Castano E, Sobol M et al (2013) Involvement of phosphatidylinositol 4,5-bisphosphate in RNA polymerase I transcription. J Cell Sci 126:2730–2739
Yu H, Fukami K, Watanabe Y et al (1998) Phosphatidylinositol 4,5-bisphosphate reverses the inhibition of RNA transcription caused by histone H1. Eur J Biochem 251:281–287
Zhu H, Bilgin M, Bangham R et al (2001) Global analysis of protein activities using proteome chips. Science 293:2101–2105
Zini N, Ognibene A, Bavelloni A et al (1996) Cytoplasmic and nuclear localization sites of phosphatidylinositol 3-kinase in human osteosarcoma sensitive and multidrug-resistant Saos-2 cells. Histochem Cell Biol 106:457–464
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Olazabal-Morán, M., González-García, A., Carrera, A.C. (2019). Functions of Nuclear Polyphosphoinositides. In: Gomez-Cambronero, J., Frohman, M. (eds) Lipid Signaling in Human Diseases. Handbook of Experimental Pharmacology, vol 259. Springer, Cham. https://doi.org/10.1007/164_2019_219
Download citation
DOI: https://doi.org/10.1007/164_2019_219
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33667-7
Online ISBN: 978-3-030-33668-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)